Wedge Capital Management L L P NC Makes New $3.25 Million Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Wedge Capital Management L L P NC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 139,865 shares of the company's stock, valued at approximately $3,245,000. Wedge Capital Management L L P NC owned about 0.08% of Option Care Health at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. grew its position in shares of Option Care Health by 128.2% in the 4th quarter. Assenagon Asset Management S.A. now owns 292,090 shares of the company's stock valued at $6,776,000 after buying an additional 164,086 shares during the last quarter. Graypoint LLC acquired a new position in shares of Option Care Health in the fourth quarter worth approximately $1,161,000. Harbor Capital Advisors Inc. boosted its holdings in Option Care Health by 2.7% in the fourth quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock valued at $4,945,000 after acquiring an additional 5,595 shares during the last quarter. Nordea Investment Management AB increased its position in Option Care Health by 6.0% during the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock valued at $2,165,000 after purchasing an additional 5,365 shares during the period. Finally, Central Pacific Bank Trust Division raised its holdings in Option Care Health by 6.9% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company's stock worth $234,000 after purchasing an additional 650 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Down 0.5 %

OPCH stock traded down $0.16 during trading on Monday, reaching $29.16. 1,265,576 shares of the stock were exchanged, compared to its average volume of 1,439,725. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The firm's 50 day moving average is $23.70 and its 200 day moving average is $27.74. The firm has a market cap of $4.96 billion, a P/E ratio of 24.50, a price-to-earnings-growth ratio of 2.44 and a beta of 1.31.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OPCH. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. JMP Securities reissued a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Truist Financial cut their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Finally, Barrington Research lifted their target price on Option Care Health from $32.00 to $33.00 and gave the stock an "outperform" rating in a report on Tuesday, January 14th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $29.86.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.